Presentations

Our Presentations

19 September 2023 – GSS Investor Presentation

This presentation provides an update on the Company's US Commercial Launch

Download the presentation slides here

4 September 2023 – Genetic Signatures (ASX:GSS)

FDA 510(k) Filing in Preparation for US Commercial Launch.

Click to download

August 2023 – Genetic Signatures’ CEO, John Melki interview for TechInvest Magazine

Dr. Melki speaking with David Tasker Managing Director of Chapter One Advisors for TechInvest Magazine

1st & 3rd August 2023 – Genetic Signatures’ CEO, John Melki at TechKnow Invest Roadshow

Dr. Melki speaking at TechKnow Invest Roadshow which was held in Queensland and Melbourne Australia August 2023

ShareCafe Webinar - GSS Dec 2022

28 October 2022 – Genetic Signatures’ CEO, John Melki, talks with Nadine Blayney from AusBiz

Genetic Signatures' CEO Dr John Melki was recently interviewed by Nadine Blayney from AusBiz about the Company’s unique 3base® technology, its advantages for detecting infectious diseases, the development pipeline, revenue sources, and plans for further investment and expansion in key international markets.

ausbiz-john-melki-webinar-thumbnail

18 October 2022 – GSS Investor Presentation

This presentation provides an update on the Company’s finance performance for FY22, progress of the Enteric Protozoan Kit in North America, and new areas of growth.

Click to download

7 September 2022 – GSS Investor Presentation

This presentation provides an update on the Company’s FY22 performance, new assay and instrument development, and key activities in North America and Europe.

Click to download

27 April 2022 – GSS Investor Presentation

This presentation provides an update on the Company’s Q3 2022 performance, highlights key achievements and activities, and features the product portfolio and developments in the product pipeline.

Click to download

20 April 2022 - AusBiz Presentation with David Koch

Genetic Signatures' CEO Dr John Melki talks with AusBiz host David Koch, discussing the advantages of 3baseTM technology for infectious disease testing, as well as the latest news and developments of the company.

27 January 2022 - Biotech Predictions Webinar Presentation

This presentation provides an update on the Company's latest activities. Watch the presentation below or download the presentation slides here

25 October 2021 - GSS Investor Presentation

This presentation provides an update on the Company's latest activities. Watch the presentation below or download the presentation slides here

13 August 2021 - Investor webinar presentation

Dr John Melki, Genetic Signatures CEO provides an overview of the Company’s specialist molecular diagnostics technology, 3base, which has the ability to screen for a wide array of infectious pathogens with a high degree of specificity in rapid time.

View presentation slides here

13 August 2021 - Investor webinar presentation

Dr John Melki, Genetic Signatures CEO will provide an overview of the Company’s specialist molecular diagnostics technology, 3baseTM which has the ability to screen for a wide array of infectious pathogens, with a high degree of specificity in rapid time.

Click here to view more details.

12 February 2021 - Genetic Signatures ShareCafe Webinar

John Melki, Director & Chief Executive Officer

 

26 November 2020- The following videos were delivered to participants at the November 2020 Bell Potter Healthcare conference.

John Buckels, Directors Sales & Support Europe

Derek Joesting, Director of Sales North America

Customer representative from Royal Marsden Hospital in London

20 November 2020- A representative from Royal Marsden Hospital in London explains why they adopted Genetic Signatures EasyScreenTM products

28 August 2020 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

28 June 2020 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

29 May 2020 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

7 November 2019 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

28 October 2019 – GSS Investor Presentation- Capital Raise

This presentation provides an update on the Company’s latest activities. Click to download

15 March 2019 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

26 November 2018 - CEO Presentation- GSS 2018 Annual General Meeting

Genetic Signatures CEO Dr. John Melki will be presenting at the GSS 2018 AGM on Thursday 29 November 2018 Click to download

15 August 2018 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

23 May 2018 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

28 November 2017 - CEO Presentation- GSS 2017 Annual General Meeting

Genetic Signatures CEO Dr. John Melki presented at the GSS 2017 AGM held on Tuesday 28 November 2017. Click to download

30 June 2017 – GSS Investor Presentation

This presentation provides an update on the Company’s latest activities. Click to download

29 November 2016 - CEO Presentation - GSS 2016 Annual General Meeting

Genetic Signatures CEO Dr. John Melki presented at the GSS 2016 AGM held on Tuesday 29 November 2016. Click to download

18 October 2016 - GSS Presentation to the Australian Microcap Conference

Chief Executive Officer, John Melki, PhD., presented on Genetic Signatures’ commercialisation progress, financial results, and achievements to date. Click to download

22 July 2015 - GSS Non-Deal Roadshow Presentation

This presentation provides an update on the Company’s activities. Click to download

09 November 2015 - CEO Presentation - GSS 2015 Annual General Meeting

Genetic Signatures CEO Dr John Melki presented at the GSS 2015 AGM held on Monday 09 November 2015. Click to download

20 October 2015 - GSS Presentation to the Australian Microcap Conference

Genetic Signatures CEO Dr. John Melki presented at the 6th Annual Australian Microcap Investment Conference held on Tuesday 20th & Wednesday 21st October 2015. Dr Melki presented on Genetic Signatures’ technology, commercialisation progress, financial results, and track record. The presentation also detailed the Company’s global revenue growth strategy for the sale of world leading solutions for the rapidly growing infectious disease detection market. Click to download

24 September 2015 - GSS Non-Deal Roadshow - 2015 Full Final Year Results Presentation

This presentation provides an update on the 2015 Full Final Year Results. Click to download

18 July 2015 - CFO Presentation at 2015 Bioshares Biotech Summit

Genetic Signatures CFO Rob Birrell presented at the 11th Bioshares Biotech Summit in Queenstown held on Friday 17- Saturday 18 July, 2015. The presentation featured in a session titled New IPOs, with a focus on biotech companies that have listed in the last 12 months, their respective IPO experiences and the value propositions of the newly listed companies. Click to download

25th May 2015 - GSS Non-Deal Roadshow Presentation

The presentation that John Melki, PhD., Director & CEO and Robert Birrell, Director & CFO, delivered to investors during a non-deal roadshow in Adelaide, Melbourne and Sydney. The presentation provides an update on the Company’s activities. Click to download